Beximco Pharmaceuticals Limited

BXP.L · LSE
Analyze with AI
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Assets
Cash & Equivalents£854£1,136£1,169£675
Short-Term Investments£200£166£108£0
Receivables£4,018£3,370£2,963£3,348
Inventory£13,015£13,473£11,573£7,805
Other Curr. Assets£2,731£2,731£2,606£1,943
Total Curr. Assets£20,818£20,876£18,419£13,771
Property Plant & Equip (Net)£43,049£42,808£42,379£36,531
Goodwill£675£675£675£547
Intangibles£4,721£4,721£4,563£1,381
Long-Term Investments-£179£21£23£17
Tax Assets£61£0£89-£17
Other NC Assets£200£57£0£17
Total NC Assets£48,526£48,281£47,729£38,475
Other Assets£0£0£0£0
Total Assets£69,344£69,157£66,148£52,246
Liabilities
Payables£3,671£1,618£1,373£769
Short-Term Debt£4,267£8,061£8,917£6,425
Tax Payable£429£454£99£223
Deferred Revenue£0£0£0£368
Other Curr. Liab.£1,194£3,132£2,347£1,565
Total Curr. Liab.£9,562£13,265£12,736£9,350
LT Debt£1,758£2,551£3,454£1,207
Deferred Rev, NC£0£0£0£2,101
Deferred Tax Liab, NC£2,575£2,550£2,537£0
Other NC Liab.£3,547£3,171£2,785£2,224
Total NC Liab.£7,879£8,272£8,776£5,532
Other Liabilities£0£0£0£0
Cap. Leases£464£540£617£348
Total Liabilities£17,441£21,537£21,512£14,881
Equity
Pref Stock£0£0£0£0
Common Stock£4,461£4,461£4,461£4,461
Retained Earnings£35,079£30,806£27,748£24,180
AOCI£1,450£1,454£1,432£1,431
Other Equity£6,959£6,959£6,959£6,959
Total Equity£47,950£43,681£40,600£37,031
Supplemental Information
Minority Interest£3,953£3,939£4,036£334
Total Liab. & Tot. Equity£69,344£69,157£66,148£52,246
Net Debt£5,171£9,476£11,202£6,956
Beximco Pharmaceuticals Limited (BXP.L) Financial Statements & Key Stats | AlphaPilot